Senti Biosciences Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Senti Biosciences Holdings Inc.
Former names
Senti Biosciences, Inc. Dynamics Special Purpose Corp.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
South SAN Francisco
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SNTI
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001854270
EIN
86-2437900

Board of directors

Chief executives

Timothy K. Lu · CEO and President
Dates unknown

Director election results

Annual meeting of October 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 8 other boards. 7 are in the same sector.

Network of Senti Biosciences Holdings Inc.'s board connections Edap TMS S.A. Edap TMS S.A. Fulcrum Therapeutics Inc. Fulcrum Therapeutics I... Lexeo Therapeutics Inc. Lexeo Therapeutics Inc... MBX Biosciences Inc. MBX Biosciences Inc. OnKure Therapeutics Inc. OnKure Therapeutics In... Rhythm Pharmaceuticals Inc. Rhythm Pharmaceuticals... Seer Inc. Seer Inc. Trevi Therapeutics Inc. Trevi Therapeutics Inc... Brenda Cooperstone Brenda Cooperstone Edward T. Mathers Edward T. Mathers Fran Schulz Fran Schulz James J. Collins James J. Collins Omid Farokhzad Omid Farokhzad Senti Biosciences Holdings...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 21, 2026 Timothy K. Lu Director, Officer (CEO) Shares withheld for tax −157,312 — —
Oct 21, 2026 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Shares withheld for tax −19,953 — —
Mar 9, 2026 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Shares withheld for tax −10,757 — —
Mar 9, 2026 Timothy K. Lu Director, Officer (CEO) Shares withheld for tax −80,666 — —
Feb 2, 2026 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Shares withheld for tax −1,384 — —
Feb 2, 2026 Timothy K. Lu Director, Officer (CEO) Shares withheld for tax −4,191 — —
Mar 10, 2025 Celadon Partners SPV 24 10% owner Derivative conversion +9,777,000 — —
Mar 10, 2025 Florence Anthony A. Jr. 10% owner Derivative conversion +3,333,000 — —
Mar 10, 2025 Bayer US Holding LP 10% owner Derivative conversion +2,222,000 — —
Mar 10, 2025 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Derivative conversion +33,000 $2.25 $74,250
Mar 7, 2025 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Grant or award +78,363 — —
Mar 7, 2025 Timothy K. Lu Director, Officer (CEO and Interim PFO and PAO) Grant or award +642,358 — —
Feb 6, 2025 Timothy K. Lu Director, Officer (CEO) Open-market sale −545 $4.36 $2,376
Feb 6, 2025 Rajangam Kanya Officer (Pres. & Chief Med. & Dev. Off.) Open-market sale −182 $4.37 $795
Feb 4, 2025 Timothy K. Lu Director, Officer (CEO) Open-market sale −3,922 $4.07 $15,963

Organizations in the same sector, closest in location and size first.

Questions about Senti Biosciences Holdings Inc.

Who is the CEO of Senti Biosciences Holdings Inc.?

Timothy K. Lu is Senti Biosciences Holdings Inc.'s CEO and President.

How many directors are on Senti Biosciences Holdings Inc.'s board?

Senti Biosciences Holdings Inc.'s board has 10 directors: Brenda Cooperstone, Bryan Daniel Baum, Donald F. Tang, Edward T. Mathers, Feng Hsiung, Fran Schulz, James J. Collins, Omid Farokhzad, Susan D. Berland and Timothy K. Lu.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="senti-biosciences-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.